- Home
- RADX vs PYN Comparison
RADX vs PYN Comparison
Compare RADX & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- PYN
- Stock Information
- Founded
- RADX 2021
- PYN 2002
- Country
- RADX Australia
- PYN United States
- Employees
- RADX N/A
- PYN N/A
- Industry
- RADX
- PYN Investment Managers
- Sector
- RADX
- PYN Finance
- Exchange
- RADX NYSE
- PYN Nasdaq
- Market Cap
- RADX 32.5M
- PYN 30.1M
- IPO Year
- RADX N/A
- PYN N/A
- Fundamental
- Price
- RADX $4.25
- PYN $5.29
- Analyst Decision
- RADX Strong Buy
- PYN
- Analyst Count
- RADX 2
- PYN 0
- Target Price
- RADX $13.50
- PYN N/A
- AVG Volume (30 Days)
- RADX 22.4K
- PYN 19.9K
- Earning Date
- RADX 02-26-2025
- PYN 01-01-0001
- Dividend Yield
- RADX N/A
- PYN 5.07%
- EPS Growth
- RADX N/A
- PYN N/A
- EPS
- RADX N/A
- PYN N/A
- Revenue
- RADX $204,609.00
- PYN N/A
- Revenue This Year
- RADX N/A
- PYN N/A
- Revenue Next Year
- RADX N/A
- PYN N/A
- P/E Ratio
- RADX N/A
- PYN N/A
- Revenue Growth
- RADX N/A
- PYN N/A
- 52 Week Low
- RADX $3.50
- PYN $4.84
- 52 Week High
- RADX $50.82
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- PYN 49.80
- Support Level
- RADX N/A
- PYN $5.25
- Resistance Level
- RADX N/A
- PYN $5.37
- Average True Range (ATR)
- RADX 0.00
- PYN 0.10
- MACD
- RADX 0.00
- PYN 0.01
- Stochastic Oscillator
- RADX 0.00
- PYN 9.59
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.